ECTRIMS Annual Meeting
The Roche MS Steering Committee share their thoughts on the importance of the ECTRIMS Annual Meeting and some of their key learnings from this year's meeting that they thought were most relevant to share with the UK clinical community. For details of the content presented please view the ECTRIMS 2019 MS Highlights Report.
- Professor Jeremy Hobart, Consultant Neurologist, University Hospitals Plymouth NHS Trust (Project co-chair)
- Dr Niraj Mistry, Consultant Neurologist, Queen Elizabeth Hospital, Birmingham (Project co-chair)
- Dr Tom Button, Consultant Neurologist, York Hospital
- Ms Rachel Dorsey-Campbell, Neurological Pharmacist, Imperial College Healthcare NHS Trust
- Dr Paul Gallagher, Consultant Neurologist, Institute of Neurological Sciences, Glasgow
- Dr Tim Harrower, Consultant Neurologist, Royal Devon and Exeter NHS Foundation Trust
- Dr Oliver Lily, Consultant Neurologist, Leeds General Infirmary
- Dr Monica Marta, Consultant Neurologist, Barts Health NHS Trust/QMUL
- Dr Gemma Maxwell, Neuro-Ophthalmology Fellow, Royal Victoria Infirmary, Newcastle-upon-Tyne
- Dr Heather Wilson, Consultant Neurologist, Royal Free London, NHS Trust
These individuals share a range of interests within the field of MS and represent a geographic spread of MS expertise across the UK.
ECTRIMS 2019 – Key Highlights
Professor Jeremy Hobart, Ms Rachel Dorsey-Campbell, Dr Niraj Mistry & Dr Tim Harrower reflect on the neurology updates they found most interesting at ECTRIMS 2019, and comment on how these findings may impact UK clinical practice, both now and in the future. Here they discuss:
- Updated data from several studies investigating treatments available for MS in progressive phases
- Implications on healthcare systems capacity
- A hot topic at ECTRIMS - vitamin D. Which dose do they recommend?
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis, MS; multiple sclerosis.
Date of preparation: August 2020